April 18, 2018

Editorial

By: OR Manager
Share

According to the US Centers for Disease Control and Prevention, nearly 2 million Americans have a prescription-related opioid use disorder, and 46 people die from a prescription opioid-related overdose every day—more than a fourfold increase since 1999.

Statistics like these are in the news nearly every day, and there is increasing pressure on lawmakers and healthcare providers to restrict use of the drug and find alternatives for pain management (cover story).

In February, the Centers for Medicare & Medicaid Services proposed new limitations for prescribing opioids to Medicare Part D patients, among them a 7-day supply for initial prescriptions for treatment of acute pain. And in March, President Trump announced an “Initiative to Stop Opioid Abuse” that focuses on cutting opioid prescriptions and punishing drug traffickers who deal fentanyl, the leading cause of drug overdose deaths in 2016.

Opioid abuse has been blamed largely on cavalier prescribing practices. In fact, a recent analysis by CNN and Harvard University researchers found some large payments made to physicians from opioid manufacturers.

According to this analysis, in 2014 and 2015, more than 200,000 physicians who wrote opioid prescriptions received payments from pharmaceutical companies that make opioids.

The authors said it was more likely that opioid manufacturers would pay physicians who wrote more prescriptions: Physicians in the top 1% of opioid prescribers received on average four times as much money as the typical physician. Physicians in the top 10th of 1%, on average, received nine times more money than the typical physician.

The analysis paints a bleak picture of unscrupulous practices that have led to dire consequences. And yet healthcare providers have known for years about the dangers of opioids, and many of them have tried to limit use of the drug.

As far back as 2000, for example, Michael A. E. Ramsay, MD, published a paper in which he cited numerous side-effects from opioids—particularly the risk of respiratory depression—and he described multimodal approaches to pain management. Numerous other studies have linked preoperative opioid use with worse outcomes, notably the University of Michigan’s 2017 study of more than 2,000 patients in the Michigan Surgical Quality Collaborative clinical registry database.

More recent research demonstrates the efficacy of non-opioid approaches to pain. In a study of total hip and knee arthroplasties, for example, fewer complications and lower lengths of stay were seen in patients who received a combination of opioids plus other analgesic modes vs opioids alone.

The study was based on more than 500,000 total hip and more than 1 million total knee arthroplasties from the Premier Perspective database for 2006 to 2016. Multimodal analgesia modes included peripheral nerve blocks, acetaminophen, steroids, gabapentin/pregabalin, ketamine, nonsteroidal anti-inflammatory drugs, or cyclooxygenase-2 inhibitors given on the day of surgery or the day after. A total of 85.6% of patients were given multimodal analgesia.

Among the total hip arthroplasty patients, there were 19% fewer respiratory complications and 26% fewer gastrointestinal complications among multimodal vs opioid-only groups, and a 12.1% decrease in length of stay (LOS) (2 vs 3 median days). The researchers note that reduced LOS did not lower overall hospitalization cost—a fact they believe could reflect “an increase in utilization of resources for monitoring and care in an increasingly comorbidity-ridden population.”

The 85.6% rate of multimodal utilization in this study shows widespread acceptance of this concept, and many professional societies support the practice. However, the authors say more studies are needed to better parse the effects of the many different possible combinations of drugs.

A few years ago, after undergoing a parotidectomy for a tumor that turned out to be benign, I asked my surgeon to prescribe Tylenol with codeine rather than the standard Percocet. I thought I would tolerate the Tylenol better, but because I could hardly eat anything, even that quickly produced severe nausea. I switched to regular Tylenol and put up with the pain as best I could.

I had been told to eat “soft foods,” but if I had it to do over again, I would manage on a liquid diet. I have a fairly high tolerance for pain, but mine was more acute than I expected it to be, and something as simple as better dietary advice could have significantly reduced my discomfort.

Pain thresholds are different for everyone, and type of procedure plays a role in those levels. When patients are opioid abusers, pain management becomes exponentially more challenging, but practices like prehabilitation, enhanced recovery after surgery, and multimodal analgesia are evidence-based best practices that produce better outcomes.

In addition to these, I would say managing patients’ expectations with a realistic and appropriate regimen for postoperative pain control is a critical component for success. ✥

 

References

https://www.cms.gov/Newsroom/MediaReleaseDatabase/Fact-sheets/2018-Fact-sheets-items/2018-02-01.html.

Johnson S R. Trump calls for death penalty for drug traffickers. Modern Healthcare. Published online March 19, 2018.

Kessler A, Cohen E, Grise K. CNN Exclusive: The more opioids doctors prescribe, the more money they make. Published online March 12, 2018. https://www.cnn.com/2018/03/11/health/prescription-opioid-payments-eprise/index.html.

Memtsoudis S G, Poeran J, Zubizarreta N, et al. Association of multimodal pain management strategies with perioperative outcomes and resource utilization. Anesthesiology. Published online March 1, 2018.

Ramsay M A E. Acute postoperative pain management. Proc (Bayl Univ Med Cent). 2000 Jul; 13(3): 244–247. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1317048/.

Wood E. Evidence-based practice supports adopting ERAS protocols. OR Manager. May 2017;33(5), 15-19.

Join our community

Learn More
Video Spotlight
Live chat by BoldChat